NCT03337373View on ClinicalTrials.gov

The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Critical IllnessRespiratory Distress Syndrome, AdultNeuromuscular BlockadeRespiratory FailureParalysisARDS, Human
Interventions
DRUG

cisatracurium

A single dose of 0.2 mg/kg intravenous bolus cisatracurium will be administered and blood samples will be taken before and at least 7 occasions post dose (at 1, 5, 10, 12, 15, 20, 30, and/or 60 minutes after a single bolus).

Trial Locations (1)

10400

Faculty of Medicine Ramathibodi Hospital, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER

NCT03337373 - The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium | Biotech Hunter | Biotech Hunter